The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

Results of the AGAVE-201 trial demonstrate a high incidence of response to axatilimab among patients with chronic graft-versus-host disease.

Researchers sought to determine factors related to complete response in managing LARC with total neoadjuvant therapy.

Patients who received optimal treatment with mitomycin C or BCG had similar recurrence-free and progression-free survival at 4 years.

Researchers sought to determine whether high antimetabolite dose intensity is related to higher treatment-induced toxicity in pediatric patients with ALL.

Under most pessimistic scenario, one dose would avert fewer cervical cancer cases with difference of 3 percent over 100 years.

Interrupting DOAC therapy before surgery can increase the risk for thrombotic events, whereas continuing these medications can increase bleeding risk. Clinicians should adopt a balanced and ...

A mouse xenograft model of DLBCL tumors was used to characterize the role of TNFAIP3 expression tumor growth. Tumors induced from cells with higher levels of TNFAIP3 had a lower volume compared with ...

Feasibility study highlights an unmet need of patients receiving palliative radiotherapy for bone metastases pain, but the intervention was not as feasible for staff.

A meta-analysis of studies showed netupitant-palonosetron more effectively prevented CINV, particularly in the overall and delayed phases, compared with aprepitant.

Researchers aimed to identify a standardized practice for the early detection of cutaneous melanoma recurrence.

The MammaPrint assay may be able to identify patients with HR+ early breast cancer who could benefit from extended letrozole therapy beyond 5 years, according to researchers.